Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors-Reference-Cited by-同舟云学术

Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors

Published:2021-06-12 Issue:22 Volume:6 Page:5504-5523
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Guo Yu¹,Xu Yaping¹,Dong Xiaowu¹^ORCID,Zhang Jianjun²

Affiliation:

1. Hangzhou Institute of Innovative Medicine College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P.R. China

2. Department of Pharmacy Institution The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine) Hangzhou 310006 P.R. China

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.202100186

Reference123 articles.

1. H. T.Philos. Trans. R. Soc. London Ser. B1998 353 583–605.

2. Combinatorial control of the specificity of protein tyrosine phosphatases

3. Protein tyrosine phosphatases: prospects for therapeutics

4. Protein kinases and phosphatases as therapeutic targets in cancer

5. Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis and Evaluation of Thioacetamide‐Tethered Thiadiazole‐1,2,4‐Triazole Hybrids as SHP2 Inhibitors for Cancer Therapy;ChemistrySelect;2024-07-12

2. Multifaceted perspectives of detecting and targeting solid tumors;International Review of Cell and Molecular Biology;2024

3. Setting sail: Maneuvering SHP2 activity and its effects in cancer;Advances in Cancer Research;2023

4. Targeting SHP2 phosphatase in hematological malignancies;Expert Opinion on Therapeutic Targets;2022-04-03

5. Proteolysis-targeting chimera molecules targeting SHP2;Future Medicinal Chemistry;2022-04